Article Image

IPFS News Link • Big Pharma

PHARMA-CREATED DISEASES trigger massive cancer risk,...

• Natural News - S D Wells

Why do so many babies, kids, teens and young adults have auto-immune disorders these days? Could it possibly be all the deadly neurotoxins in the 70 vaccines they get stuck with before age 7? Could it have to do with the prescription quack drugs that are made with deadly venom peptides from scorpions, rattle snakes, lizards, frogs and wasps? Let's take a close look at the science, and how this is all driving cancer risks and rates through the roof.

A landmark study of over 1.5 million patients has uncovered a strong connection between autoimmune diseases and increased cancer risk, revealing patterns that could reshape how both patients and doctors approach these conditions. The findings show that chronic inflammation from autoimmune diseases such as celiac disease, lupus, and type 1 diabetes can elevate the risk of several cancers, particularly in the digestive system, while multiple sclerosis (MS) may unexpectedly lower certain cancer risks.

• Large-scale study of 1.5M patients found several autoimmune diseases—like celiac, lupus, and type 1 diabetes—significantly increase risks for certain digestive cancers, likely due to chronic inflammation and immune suppression from treatments.

• Celiac disease patients had a 319% higher small intestine cancer risk, lupus patients more than doubled liver cancer risk, and type 1 diabetics showed elevated risks across most digestive cancers; in contrast, multiple sclerosis was linked to lower risks for some cancers.

• Experts recommend aggressive inflammation management through anti-inflammatory diets, gut health support, stress reduction, detox support, and working with holistic practitioners to balance immune function without triggering flares.

• Patients with autoimmune diseases should consider more frequent cancer screenings and inflammation monitoring, as proactive prevention may protect long-term health beyond daily symptom control.


AzureStandard